WallStSmart

Calumet Specialty Products Partners (CLMT)vsSherwin-Williams Co (SHW)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 443% more annual revenue ($24.91B vs $4.59B). SHW leads profitability with a 10.7% profit margin vs -3.0%. CLMT appears more attractively valued with a PEG of 0.65. SHW earns a higher WallStSmart Score of 56/100 (C).

CLMT

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.84

SHW

Buy

56

out of 100

Grade: C

Growth: 4.7Profit: 8.0Value: 4.0Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLMTSignificantly Overvalued (-70.0%)

Margin of Safety

-70.0%

Fair Value

$15.11

Current Price

$39.64

$24.53 premium

UndervaluedFair: $15.11Overvalued
SHWOvervalued (-7.6%)

Margin of Safety

-7.6%

Fair Value

$337.95

Current Price

$344.10

$6.15 premium

UndervaluedFair: $337.95Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLMT4 strengths · Avg: 9.5/10
Revenue GrowthGrowth
40.8%10/10

Revenue surging 40.8% year-over-year

EPS GrowthGrowth
562.0%10/10

Earnings expanding 562.0% YoY

Debt/EquityHealth
-1.9910/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.658/10

Growing faster than its price suggests

SHW2 strengths · Avg: 9.5/10
Return on EquityProfitability
67.3%10/10

Every $100 of equity generates 67 in profit

Market CapQuality
$80.35B9/10

Large-cap with strong market position

Areas to Watch

CLMT4 concerns · Avg: 1.5/10
Return on EquityProfitability
-1172.0%2/10

ROE of -1172.0% — below average capital efficiency

Altman Z-ScoreHealth
0.842/10

Distress zone — elevated risk

Profit MarginProfitability
-3.0%1/10

Currently unprofitable

Operating MarginProfitability
-4.6%1/10

Operating margin of -4.6%

SHW4 concerns · Avg: 4.0/10
PEG RatioValuation
2.144/10

Expensive relative to growth rate

P/E RatioValuation
30.6x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
0.9%4/10

0.9% earnings growth

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CLMT

The strongest argument for CLMT centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 40.8% demonstrates continued momentum. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap.

Bear Case : CLMT

The primary concerns for CLMT are Return on Equity, Altman Z-Score, Profit Margin.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, EPS Growth. Debt-to-equity of 3.52 is elevated, increasing financial risk.

Key Dynamics to Monitor

CLMT profiles as a hypergrowth stock while SHW is a value play — different risk/reward profiles.

SHW carries more volatility with a beta of 1.08 — expect wider price swings.

CLMT is growing revenue faster at 40.8% — sustainability is the question.

SHW generates stronger free cash flow (976M), providing more financial flexibility.

Bottom Line

CLMT scores higher overall (56/100 vs 56/100) and 40.8% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Calumet Specialty Products Partners

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Calumet Specialty Products Partners, LP produces and sells specialty hydrocarbon products in North America and internationally. The company is headquartered in Indianapolis, Indiana.

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?